Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

23.20SEK
25 Nov 2014
Price Change (% chg)

-0.40kr (-1.69%)
Prev Close
23.60kr
Open
23.60kr
Day's High
23.80kr
Day's Low
23.20kr
Volume
47,936
Avg. Vol
--
52-wk High
--
52-wk Low
--

ACTI.ST

Chart for ACTI.ST

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)

Overall

Beta: 1.85
Market Cap (Mil.): kr1,768.20
Shares Outstanding (Mil.): 74.92
Dividend: --
Yield (%): --

Financials

  ACTI.ST Industry Sector
P/E (TTM): -- 229.94 39.18
EPS (TTM): -3.42 -- --
ROI: -43.80 -2.11 17.24
ROE: -71.05 -3.28 18.11
Search Stocks

BRIEF-Active Biotech Q3 operating loss SEK 56 mln

STOCKHOLM, Nov 5 - Active Biotech Ab, July-September:

05 Nov 2014

BRIEF-Active Biotech and Teva expand Laquinimod clinical development program

* Teva and Active Biotech announce expansion of Laquinimod clinical development program with new trial in primary progressive multiple sclerosis and first patient screened in Huntington's Disease trial Source text for Eikon: Further company coverage:

04 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks